手紙:男性における亜鉛欠乏症

TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer.

ESMO open·2026

Treatment of chronic recalcitrant gluteal trochanteric pain syndrome with dry needling and electrical stimulation: A case study.

Journal of bodywork and movement therapies·2026

Beyond access: Uncovering hidden public health benefits of participating in experimental medicine trials through detection of clinically significant findings at screening.

Public health·2026

Indigenous Australians' Oral Health Care Experiences: Recommendations for Culturally Safe Dental Care.

JDR clinical and translational research·2025

TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

RETRACTED: An analysis of applications and acceptances to the National Specialist Training Programme in General Practice Ireland from 2021-2024.

Irish medical journal·2025

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

EvoDiffMol: evolutionary diffusion framework for 3D molecular design with optimized properties.

Journal of cheminformatics·2026

Harnessing genetic, chemical, and transcriptomic analyses guided the selection of Cistus creticus subsp. creticus genotypes rich in labdane-type diterpenes.

Planta·2026

Metabolic profiling-based screening of potential hepatotoxic combinations in green tea components under non-specific reactive oxygen species-removal cellular conditions.

Food & function·2026

Sustainable pH sensing: repurposing the anthocyanin-rich extract from Dioscorea alata for green analytical chemistry.

RSC advances·2026

mRNA decapping proteins regulate EIN2-dependent ethylene signaling in arabidopsis.

Frontiers in plant science·2026

Correction: İnce et al. Controlled and Modified Atmospheres Combined with 1-MCP Improve Postharvest Quality and Suppress Botrytis cinerea in Cut Roses (Rosa hybrida L.). Plants 2026, 15, 1452.

Plants (Basel, Switzerland)·2026

関連する実験動画

手紙:男性における亜鉛欠乏症

関連する概念動画

TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer.

Treatment of chronic recalcitrant gluteal trochanteric pain syndrome with dry needling and electrical stimulation: A case study.

Beyond access: Uncovering hidden public health benefits of participating in experimental medicine trials through detection of clinically significant findings at screening.

Indigenous Australians' Oral Health Care Experiences: Recommendations for Culturally Safe Dental Care.

TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer.

RETRACTED: An analysis of applications and acceptances to the National Specialist Training Programme in General Practice Ireland from 2021-2024.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

EvoDiffMol: evolutionary diffusion framework for 3D molecular design with optimized properties.

Harnessing genetic, chemical, and transcriptomic analyses guided the selection of Cistus creticus subsp. creticus genotypes rich in labdane-type diterpenes.

Metabolic profiling-based screening of potential hepatotoxic combinations in green tea components under non-specific reactive oxygen species-removal cellular conditions.

Sustainable pH sensing: repurposing the anthocyanin-rich extract from Dioscorea alata for green analytical chemistry.

mRNA decapping proteins regulate EIN2-dependent ethylene signaling in arabidopsis.

Correction: İnce et al. Controlled and Modified Atmospheres Combined with 1-MCP Improve Postharvest Quality and Suppress Botrytis cinerea in Cut Roses (Rosa hybrida L.). Plants 2026, 15, 1452.

関連する実験動画

手紙:男性における亜鉛欠乏症

関連する概念動画

関連記事